New medicinal products and procedures must meet very strict safety criteria before being applied for use in humans. The laboratory procedures involved require the use of large numbers of animals each year. Furthermore, such investigations do not always give an accurate translation to the human setting. Here, we propose a viable alternative to animal testing, which uses novel technology featuring human cord and cord blood stem cells. With over 130 million children born each year, cord and cord blood remains the most widely available alternative to the use of animals or cadaveric human tissues for in vitro toxicology.
Anon. (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC and 2000/21/EC. Official Journal of the European UnionL396, 30.12.2006, 1–849. Also available at: http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l_396/l_39620061230en00010849.pdf (Accessed 08.04.10).
2.
Anon. (2007). Commission Staff Working Document. Annex to the: Report from the Commission to the Council and the European Parliament. Fifth Report on the Statistics on the Number of Animals Used for Experimental and Other Scientific Purposes in the Member States of the European Union, 277pp. Brussels, Belgium: Commission of the European Communities. Available at: http://ec.europa.eu/environment/chemicals/lab_animals/pdf/staff_work_doc_sec1455.pdf (Accessed 08.04.10).
3.
Anon. (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European UnionL358, 18.12.1986, 1–28. Also available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31986L0609:EN:HTML (Accessed 08.04.10).
4.
McKeanC., TangL., BillamM., TangM., TheodorakisC.W., KendallR.J. & WangJ.S. (2006). Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. Journal of Applied Toxicology26, 139–147.
5.
ZhaoL., KrishnanS., ZhangY., SchenkmanJ.B. & RuslingJ.F. (2009). Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors. Chemical Research in Toxicology22, 341–347.
6.
RietjensI.M., BoersmaM.G., ZaleskaM. & PuntA. (2008). Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling. Toxicology in Vitro22, 1890–1901.
7.
PaulsenM.T. & LjungmanM. (2005). The natural toxin juglone causes degradation of p53 and induces rapid H2AX phosphorylation and cell death in human fibroblasts. Toxicology & Applied Pharmacology209, 1–9.
8.
PetitE., LangouetS., AkhdarH., Nicolas-NicolazC., GuillouzoA. & MorelF. (2008). Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes. Toxicology in Vitro22, 632–642.
9.
LasferM., VadrotN., AoudjehaneL., ContiF., BringuierA.F., FeldmannG. & Reyl-DesmarsF. (2008). Cadmium induces mitochondria-dependent apoptosis of normal human hepatocytes. Cell Biology & Toxicology24, 55–62.
10.
LaiJ.C., LaiM.B., JandhyamS., DukhandeV.V., BhushanA., DanielsC.K. & LeungS.W. (2008). Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. International Journal of Nanomedicine3, 533–545.
11.
YannasI.V., BurkeJ.F., OrgillD.P. & SkrabutE.M. (1982). Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science, New York215, 174–176.
12.
JurgaM., LipkowskiA.W., LukomskaB., BuzanskaL., KurzepaK., SobanskiT., HabichA., CoeckeS., GajkowskaB. & Domanska-JanikK. (2009). Generation of functional neural artificial tissue from human umbilical cord blood stem cells. Tissue Engineering Part C15, 365–372.
13.
Preynat-SeauveO., SuterD.M., TirefortD., TurchiL., VirolleT., ChneiweissH., FotiM., LobrinusJ.A., StoppiniL., FekiA., Dubois-DauphinM. & KrauseK.H. (2009). Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells27, 509–520.
14.
EirakuM., WatanabeK., Matsuo-TakasakiM., KawadaM., YonemuraS., MatsumuraM., WatayaT., NishiyamaA., MugurumaK. & SasaiY. (2008). Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell3, 519–532.
15.
McGuckinC.P., ForrazN., BaradezM.O., NavranS., ZhaoJ., UrbanR., TiltonR. & DennerL. (2005). Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Proliferation38, 245–255.
16.
KazemnejadS., AllamehA., SoleimaniM., Ghareh baghianA., MohammadiY., AmirizadehN. & JazayeryM. (2009). Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold. Journal of Gastroenterology & Hepatology24, 278–287.
17.
MetcalfeA.D. & FergusonM.W. (2007). Tissue engineering of replacement skin: The crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. Journal of the Royal Society Interface4, 413–437.
18.
BodnarC.A., SenA., KallosM.S., BehieL.A., PetropavlovskaiaM. & RosenbergL. (2006). Characterization of human islet-like structures generated from pancreatic precursor cells in culture. Biotechnology & Bioengineering93, 980–988.
19.
HabibM., CaspiO. & GepsteinL. (2008). Human embryonic stem cells for cardiomyogenesis. Journal of Molecular & Cellular Cardiology45, 462–474.
20.
ChenM., XieH.Q., DengL., LiX.Q., WangY., ZhiW. & YangZ.M. (2008). Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro. Cell Proliferation41, 336–347.
21.
KonigG., McAllisterT.N., DusserreN., GarridoS.A., IyicanC., MariniA., FiorilloA., AvilaH., WystrychowskiW., ZagalskiK., MaruszewskiM., JonesA.L., CierpkaL., de la FuenteL.M. & L'HeureuxN. (2009). Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials30, 1542–1550.
22.
ShinokaT. & BreuerC. (2008). Tissue-engineered blood vessels in pediatric cardiac surgery. Yale Journal of Biology & Medicine81, 161–166.
23.
PrinsH.J., RozemullerH., Vonk-GriffioenS., VerweijV.G., DhertW., Slaper-CortenbachI. & MartensA.C. (2009). Bone forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Engineering Part A5, 3741–3751.
24.
TadokoroM., KanaiR., TaketaniT., UchioY., YamaguchiS. & OhgushiH. (2009). New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. Journal of Pediatrics154, 924–930.
25.
StokK.S., LisignoliG., CristinoS., FacchiniA. & MüllerR. (2010). Mechano-functional assessment of human mesenchymal stem cells grown in three-dimensional hyaluronan-based scaffolds for cartilage tissue engineering. Journal of Biomedical Materials Research Part A93, 37–45.
26.
BuillesN., JustinV., AndréV., BurillonC. & DamourO. (2007). Reconstructed corneas: effect of three-dimensional culture, epithelium, and tetracycline hydrochloride on newly synthesized extracellular matrix. Cornea26, 1239–1248.
NigamS.K., WuW. & BushK.T. (2008). Organogenesis forum lecture: In vitro kidney development, tissue engineering and systems biology. Organogenesis4, 137–143.
29.
GuillouzoA. & Guguen-GuillouzoC. (2008). Evolving concepts in liver tissue modeling and implications for in vitro toxicology. Expert Opinion in Drug Metabolism & Toxicology4,1279–1294.
30.
BuzanskaL., HabichA., JurgaM., SypeckaJ. & Domanska-JanikK. (2005). Human cord blood-derived neural stem cell line — possible implementation in studying neurotoxicity. Toxicology in Vitro19, 991–999.
31.
UchinoT., TakezawaT. & IkarashiY. (2009). Reconstruction of three-dimensional human skin model composed of dendritic cells, keratinocytes and fibroblasts utilizing a handy scaffold of collagen vitrigel membrane. Toxicology in Vitro23, 333–337.
32.
PolakJ., MantalarisS. & HardingS.E. (eds) (2008). Advances in Tissue Engineering, 948pp. London, UK: Imperial College Press.
33.
YamanakaS. (2009). A fresh look at iPS cells. Cell137, 13–17.
HentzeH., SoongP.L., WangS.T., PhillipsB.W., PuttiT.C. & DunnN.R. (2009). Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Research, Feb 12 2009, E-pub ahead of print.
36.
McGuckinC.P. & ForrazN. (2008). Umbilical cord blood stem cells — an ethical source for regenerative medicine. Medical Law27, 147–165.
37.
McGuckinC.P. & ForrazN. (2008). Potential for access to embryonic-like cells from human umbilical cord blood. Cell Proliferation41, Suppl., 131–140.
38.
GluckmanE. & RochaV. (2009). Cord blood transplantation: State of the art. Haematologica94, 451–454.
39.
BuzanskaL., JurgaM. & Domanska-JanikK. (2006). Neuronal differentiation of human umbilical cord blood neural stem-like cell line. Neurodegenerative Diseases3, 19–26.
40.
KozlowskaH., JablonkaJ., JanowskiM., JurgaM., KossutM. & Domanska-JanikK. (2007). Transplantation of a novel human cord blood-derived neural-like stem cell line in a rat model of cortical infarct. Stem Cells & Development16, 481–488.
41.
TambuyzerB.R., BergwerfI., De VochtN., ReekmansK., DaansJ., JorensP.G., GoossensH., YsebaertD.K., ChatterjeeS., Van MarckE., BernemanZ.N. & PonsaertsP. (2009). Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunology & Cell Biology87, 267–273.
42.
SarnowskaA., JurgaM., BuzanskaL., FilipkowskiR.K., DuniecK. & Domanska-JanikK. (2008). Bilateral interaction between cord blood-derived human neural stem cells and organotypic rat hippocampal culture. Stem Cells & Development18, 1191–1200.
43.
YatesC., ShepardC.R., PapworthG., DashA., Beer StolzD., TannenbaumS., GriffithL. & WellsA. (2007). Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Advances in Cancer Research97, 225–246.
44.
VerrillC., DaviesJ., Millward-SadlerH., SundstromL. & SheronN. (2002). Organotypic liver culture in a fluid–air interface using slices of neonatal rat and adult human tissue — a model of fibrosis in vitro. Journal of Pharmacological & Toxicological Methods48, 103–110.
45.
MartinM.J., MuotriA., GageF. & VarkiA. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nature Medicine11, 228–232.
46.
XuR.H., PeckR.M., LiD.S., FengX., LudwigT. & ThomsonJ.A. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nature Methods2, 185–190.
47.
XuC., InokumaM.S., DenhamJ., GoldsK., KunduP., GoldJ.D. & CarpenterM.K. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nature Biotechnology19, 971–974.
48.
AliH., JurgaM., KurgonaiteK., ForrazN. & McGuckinC. (2009). Defined serum-free culturing conditions for neural tissue engineering of human cord blood stem cells. Acta Neurobiology Experiments (Warsaw)69, 12–23.
49.
McGuckinC., JurgaM., AliH., StrbadM. & ForrazN. (2008). Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nature Protocols3, 1046–1055.
50.
CamposL.S., DeckerL., TaylorV. & SkarnesW. (2006). Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells. Journal of Biological Chemistry281, 5300–5309.
51.
QianH., Georges-LabouesseE., NyströmA., DomogatskayaA., TryggvasonK., JacobsenS.E. & EkblomM. (2007). Distinct roles of integrins alpha6 and alpha4 in homing of fetal liver hematopoietic stem and progenitor cells. Blood110, 2399–2407.
52.
PrestwichG.D. (2007). Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. Journal of Cellular Biochemistry101, 1370–1383.
NakanishiT. (2007). The problem of species comparison of developmental toxicity: can we extrapolate human developmental toxicity induced by environmental chemicals from the data on rodents?Yakugaku Zasshi127, 491–500.
55.
HabichA., JurgaM., MarkiewiczI., LukomskaB., Bany-LaszewiczU. & Domanska-JanikK. (2006). Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Experimental Hematology34, 914–925.
56.
JurgaM., BuzañskaL., MaleckiM., HabichA. & Domañska-JanikK. (2006). Function of ID1 protein in human cord blood-derived neural stem-like cells. Journal of Neuroscience Research84, 993–1002.
